Masuda N, Ono M, Mukohara T, Yasojima H, et al. Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort. Eur J Cancer 2022;168:108-118.
PMID: 35500404